Impact of endothelin a receptor antagonist selectivity in chronic nitric oxide synthase inhibition-induced fetal growth restriction in the rat

Hypertension in Pregnancy

Volumn 29, Issue 3, 2010, Pages 284-293

  Neerhof, Mark G ^a,b   Synowiec, Sylvia ^a   Khan, Saira ^a   Thaete, Larry G ^a,b  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Endothelin antagonism; Fetal growth restriction; Nitric oxide; Perfusion; Rat

Indexed keywords

2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; ABT 546; ATRASENTAN; ENDOTHELIN A RECEPTOR ANTAGONIST; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; FETUS; FETUS GROWTH; FETUS WEIGHT; GESTATIONAL AGE; INTRAUTERINE GROWTH RETARDATION; MALE; NONHUMAN; PLACENTA CIRCULATION; PLACENTA DEVELOPMENT; PLACENTA PERFUSION; PLACENTA WEIGHT; RAT; ANALYSIS OF VARIANCE; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DRUG EFFECTS; METABOLISM; PREGNANCY; SPRAGUE DAWLEY RAT; UTERUS;

ANALYSIS OF VARIANCE; ANIMALS; ENDOTHELIN RECEPTOR ANTAGONISTS; FEMALE; FETAL GROWTH RETARDATION; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ENDOTHELIN; UTERUS;

EID: 77955113838     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641950902777739     Document Type: Article

References (41)

1. Manning FA. Fetal Medicine. Principles and Practice. Norwalk: Appleton & Lange, 1995. p. 322.
2. Cameron IT, Bacon CR, Collett GP, Davenport AP. Endothelin expression in the uterus. J Steroid Biochem Mol Biol 1995; 53:209-214.
3. Stjernquist M, Bodelsson G, Poulsen H. Vasoactive peptides and uterine vessels. Gynecol Endocrinol 1995; 9:165-176.
4. Carbillon L, Uzan M, Uzan S. Pregnancy, vascular tone, and maternal hemodynamics: a crucial adaptation. Obstet Gynecol Surv 2000; 55:574-581.
5. Chang K, Lubo Z. Review article: steroid hormones and uterine vascular adaptation to pregnancy. Reprod Sci 2008; 15:336-348.
6. Cervar M, Puerstner P, Kainer F, Desoye G. Endothelin-1 stimulates the proliferation and invasion of first trimester trophoblastic cells in vitro-A possible role in the etiology of preeclampsia? J Investig Med 1996; 44:447-453.
7. Shichiri M, Kato H, Marumo F, Hirata Y. Endothelin-1 as an autocrine/paracrine apoptosis survival factor for endothelial cells. Hypertension 1997; 30:1198-1203. (Pubitemid 27476179)
8. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990; 348:730-732. (Pubitemid 120015147)
9. Fukuroda T, Fujikawa T, Ozaki S, Ishikawa K, Yano M, Nishikibe M. Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun 1994; 199:1461-1465.
10. Thaete LG, Neerhof MG, Silver RK. Differential effects of endothelin A and B receptor antagonism on fetal growth in normal and nitric oxide-deficient rats. J Soc Gynecol Investig 2001; 8:18-23.
11. Thaete LG, Kushner DM, Dewey ER, Neerhof MG. Endothelin and the regulation of uteroplacental perfusion in nitric oxide synthase inhibition-induced fetal growth restriction. Placenta 2005; 26:242-250.
12. Madsen KM, Neerhof MG, Wessale JL, Thaete LG. Influence of ETB receptor antagonism on pregnancy outcome in rats. J Soc Gynecol Investig 2001; 8:239-244.
13. Molnar M, Suto T, Toth T, Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol 1994; 170:1458-1466.
14. Kourembanas S, McQuillan LP, Leung GK, Faller DV. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest 1993; 92:99-104.
15. Edwards DL, Arora CP, Bui DT, Castro LC. Long-term nitric oxide blockade in the pregnant rat: Effects on blood pressure and plasma levels of endothelin-1. Am J Obstet Gynecol 1996; 175:484-488.
16. Goligorsky MS, Tsukahara H, Magazine H, Andersen TT, Malik AB, Bahou WF. Termination of endothelin signaling: Role of nitric oxide. J Cell Physiol 1994; 158:485-494.
17. Thompson A, Valeri CR, Lieberthal W. Endothelin receptor A blockade alters hemodynamic response to nitric oxide inhibition in rats. Am J Physiol 1995; 269 (Heart Circ Physiol 38):H743-H748.
18. Maric C, Aldred GP, Antoine AM, Eitle E, Dean RG, Williams DA, Harris PJ, Alcorn D. Actions of endothelin-1 on cultured rat renomedullary interstitial cells are modulated by nitric oxide. Clin Exp Pharmacol Physiol 1999; 26:392-398.
19. Neerhof MG, Jilling T, Synowiec S, Khan S, Thaete LG. Altered Endothelin Receptor Binding in Response to Nitric Oxide Synthase Inhibition in the Pregnant Rat. Reprod Sci 2008; 15:366-373.
20. Diket AL, Pierce MR, Munshi UK, Voelker CA, Eloby-Childress S, Greenberg SS, Zhang X-J, Clark DA, Miller MJS. Nitric oxide inhibition causes intrauterine growth retardation and hind-limb disruptions in rats. Am J Obstet Gynecol 1994; 171:1243-1250.
21. Wight E, Küng CF, Moreau P, Takase H, Lüscher TF. Chronic blockade of nitric oxide-synthase and endothelin receptors during pregnancy in the rat: effect on pregnancy outcome. J Soc Gynecol Investig 1998; 5:132-139. (Pubitemid 28248538)
22. Opgenorth TJ, Adler AL, Calzadilla SV, Chiou WJ, Dayton BD, Dixon DB, Gehrke LJ, Hernandez L, Magnuson SR, et al. Pharmacological characterization of A-127722: An orally active and highly potent ETA-selective receptor antagonist. J Pharmacol Exp Ther 1996; 276:473-481.
23. Sogabe K, Nirei H, Shoubo M, Nomoto A, Ao S, Notsu Y, Ono T. Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist. J Pharmacol Exp Ther 1993; 264:1040-1046. (Pubitemid 23318591)
24. Wu-Wong JR, Dixon DB, Chiou WJ, Sorensen BK, Liu G, Jae H-S, Tasker A, von Geldern TW, Winn M, et al. Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A- 182086 and A-192621: in vitro studies. Clin Sci 2002; 103 (Suppl. 48):107S-111S. (Pubitemid 35007132)
25. Thaete LG, Neerhof MG, Caplan MS. Endothelin receptor A antagonism prevents hypoxiainduced intrauterine growth restriction in the rat. Am J Obstet Gynecol 1997; 176:73-76.
26. Thaete LG, Dewey ER, Neerhof MG. Endothelin and the regulation of uterine and placental perfusion in hypoxia-induced fetal growth restriction. J Soc Gynecol Investig 2004; 11:16-21.
27. Tuma RF, Vasthare US, Irion GL, Wiedeman MP. Considerations in use of microspheres for flow measurements in anesthetized rat. Am J Physiol 1986; 250:H137-H143.
28. Miller MJS, Voelker CA, Olister S, Thompson JH, Zhang X-J, Rivera D, Eloby-Childress S, Liu X, Clark DA, et al. Fetal growth retardation in rats may result from apoptosis: role of peroxynitrite. Free Radical Biol Med 1996; 21:619-629. (Pubitemid 26331092)
29. Tsukimori K, Komatsu H, Fukushima K, Kaku T, Nakano H, Wake N. Inhibition of nitric oxide synthetase at mid-gestation in rats is associated with increases in arterial pressure, serum tumor necrosis factor-alpha, and placental apoptosis. Am J Hypertens 2008; 21:477-481.
30. Ajne G, Nisell H, Jansson T. Effects of blockade of the endothelin receptor A and inhibition of nitric oxide synthesis on uteroplacental and renal blood flow in awake pregnant rats. Am J Obstet Gynecol 2005; 192:295-301.
31. Berthold H, Just A, Kirchheim HR, Ehmke H. Interaction between nitric oxide and endogenous vasoconstrictors in control of renal blood flow. Hypertension 1999; 34:1254-1258. (Pubitemid 30002391)
32. Kramp R, Fourmanoir P, Caron N. Endothelin resets renal blood flow autoregulatory efficiency during acute blockade of NO in the rat. Am J Physiol 2001; Renal Physiol. 281:F1132-F1140.
33. Danielson LA, Kercher LJ, Conrad KP. Impact of gender and endothelin on renal vasodilation and hyperfiltration induced by relaxin in conscious rats. Am J Physiol 2000; 279 (Regulatory Integrative Comp. Physiol.):R1298-R1304.
34. Gandley RE, Conrad KP, McLaughlin MK. Endothelin and nitric oxide mediate reduced myogenic reactivity of small renal arteries from pregnant rats. Am J Physiol Regulat Integr Comp Physiol 2001; 280:R1-R7.
35. Ajne G, Nisell H, Wolff K, Jansson T. The role of endogenous endothelin in the regulation of uteroplacental and renal blood flow during pregnancy in conscious rats. Placenta 2003; 24:813-818.
36. Schmidt A, Bayerle-Eder M, Pleiner H, Zeisner C, Wolzt M, Mayer G, Schmetterer L. The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelinA receptor antagonist in men. Nitric Oxide: Biology and Chemistry 2001; 5:370-376.
37. Thaete LG, Neerhof MG. Endothelin and platelet-activating factor: Significance in the pathophysiology of ischemia/reperfusion-induced fetal growth restriction in the rat. Am J Obstet Gynecol 2006; 194:1377-1383.
38. Dhaun N, Pollock DM, Goddard J, Webb DJ. Selective and mixed endothelin receptor antagonism in cardiovascular disease. Trends Pharmacol Sci 2007; 28:573-579.
39. Dhaun N, Goddard J, Webb DJ. The endothelin system and its antagonism in chronic kidney disease. J Am Soc Nephrol 2006; 17:943-955.
40. Treinen KA, Louden C, Dennis MJ, Wier PJ. Developmental toxicity and toxicokinetics of two endothelin receptor antagonists in rats and rabbits. Teratology 1999; 59:51-59.
41. Spence S, Anderson C, Cukierski M, Patrick D. Teratogenic effects of the endothelin receptor antagonist L-753,037 in the rat. Reprod Toxicol 1999; 13:15-29.